Evidence map›Paper›PMID 42912927›Full record

ArticleJournal of chemical information and modeling2026

CAPRICHO: Interpretable Quality Flagging and Flexible ChEMBL Bioactivity Curation for QSAR Modeling.

David Alencar Araripe, Srijit Seal, Olivier J M Béquignon, Gerard J P van Westen

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David Alencar AraripeDivision of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CCLeiden, The Netherlands.
Srijit SealHuman Chemical Company, San Francisco, California94129, United States.ORCID 0000-0003-2790-8679
Olivier J M BéquignonDivision of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CCLeiden, The Netherlands.ORCID 0000-0002-7554-9220
Gerard J P van WestenDivision of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CCLeiden, The Netherlands.ORCID 0000-0003-0717-1817

Funding

European Union?s Horizon 2020 research and innovation program under the Marie Sklodowska Curie grant 955879
6 · The paper itself

Abstract

Preparing ChEMBL bioactivity data for quantitative structure-activity relationship (QSAR) modeling requires navigating curation decisions that often lack documentation and are hard to reproduce. We present CAPRICHO (ChEMBL Aggregation Package with Robust Inspection and Curation Handling Options), a Python command-line tool addressing two gaps in current workflows: transparency and flexibility. Unlike approaches that remove problematic data, CAPRICHO flags quality issues while preserving all data for inspection, letting users assess how each curation decision affects cross-assay comparability. Aggregation is configured via customizable grouping columns, supporting both traditional QSAR and emerging assay-aware modeling paradigms, with all parameters recorded in recipe files for reproducibility. Three case studies demonstrate the tool: (i) programmatic support of ChEMBL max-curation standards, (ii) CYP inhibition multitask curation, and (iii) Caco-2 permeability with unit standardization. Together, these show that preserving rather than removing flagged data lets practitioners identify which quality issues most affect comparability and balance data quality with availability for QSAR modeling. CAPRICHO is freely available at https://github.com/CDDLeiden/Capricho.

Indexed as

Data CurationQuantitative Structure-Activity RelationshipSoftwareBiocurationCaco-2 CellsHumans

Identifiers

PMID42912927
PMCPMC13663851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.